Skip to main content
Maria Suarez-Almazor, MD, Rheumatology, Houston, TX, University of Texas M.D. Anderson Cancer Center

MariaEugeniaSuarez-AlmazorMD

Rheumatology Houston, TX

Chief, Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, Division of Internal Medicine; Deputy Department Chair (Research), Department of General Internal Medicine, Division of Internal Medicine; Barnts Family Distinguished Professor, Department of General Internal Medicine, Division of Internal Medicine at The University of Texas MD Anderson Cancer Center

Dr. Suarez-Almazor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Suarez-Almazor's full profile

Already have an account?

Education & Training

  • University of Buenos Aires
    University of Buenos AiresClass of 1979

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 2006 - 2026
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
  • Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018
  • Myositis as an Adverse Event of Immune Checkpoint Blockade for Cancer TherapyMay 2018

Press Mentions

  • For Men on ADT, Checking Bone Density May Thwart Fractures
    For Men on ADT, Checking Bone Density May Thwart FracturesApril 1st, 2022
  • With Autoimmunity, Checkpoint Inhibitors Can Be Used
    With Autoimmunity, Checkpoint Inhibitors Can Be UsedAugust 14th, 2019
  • Immune‐Related Adverse Events with the Use of Checkpoint Inhibitors for Immunotherapy of Cancer
    Immune‐Related Adverse Events with the Use of Checkpoint Inhibitors for Immunotherapy of CancerJanuary 14th, 2017

Grant Support

  • Outcomes Research In Rheumatic Diseases: A Mentoring ProgramNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2011
  • Adaptation Of Consumer Guides For Patients With Low Health LiteracyAgency For Healthcare Research And Quality2010
  • Patient Awareness And Consumer Education Research Cente*Agency For Healthcare Research And Quality2006–2010
  • Cognitive Behavioral Determinants In Knee ReplacementNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2007
  • Treatment Adherence In Minorities With Rheumatic DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006
  • Patient Awareness And Consumer Education Research Cente*Agency For Healthcare Research And Quality2006
  • Treatment Adherence In Minorities With Rheumatic DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2006
  • Patient-Provider Interaction &Response To AcupunctureNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005
  • Cognitive Behavioral Determinants In Knee ReplacementNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2005
  • Patient-Provider Interaction &Response To AcupunctureNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2005
  • Health Values &Preferences In OsteoarthritisAgency For Healthcare Research And Quality2000–2002

Professional Memberships

Hospital Affiliations